Pharmacogenomics in HIV Treatment focuses on how genetic variations impact antiretroviral therapy outcomes. It discusses genetic markers that predict drug efficacy, resistance, and toxicity in HIV patients. The book highlights personalized treatment plans to enhance viral suppression and patient adherence. Suitable for infectious disease specialists and pharmacogenomic researchers, it promotes optimized HIV management through genetic insights.
Heather Peterson specializes in pharmacogenomics within HIV treatment, focusing on managing dermatological complications associated with HIV therapies. Her research explores how genetic variations influence the response to antiretroviral medications used in treating HIV-related skin conditions like Kaposi sarcoma. Heather has published extensively on personalizing HIV pharmacotherapy to enhance dermatological outcomes and reduce adverse effects through pharmacogenomic testing. She also provides guidelines for clinicians to utilize pharmacogenomic insights in managing HIV-related dermatological care, promoting personalized and effective treatments through genetic-informed strategies.